The annual conference taking place from June 1 to June 5, 2024, will feature sessions on the relationship between mental health and sleep, artificial intelligence in sleep, and different sleep conditions.
The Associated Professional Sleep Societies, LLC, will host their annual conference meeting in Houston, Texas, from June 1 to June 5, 2024. SLEEP 2024 will cover a variety of different subjects, including sleep in adolescents, sleep health inequities, and the influence of sleep on different mental health disorders.
The general sessions of the meeting start on June 2, with the majority of presentations held from Monday, June 3, to Wednesday, June 5. The plenary session and keynote address by Gina Poe, PhD, will open the general sessions part of the meeting on Monday morning. Then, abstract presentations and different sessions are open to attendees.
Alarm clock | Image credit: netrun78 - stock.adobe.com
Health inequities are a hot-button topic in medicine, and this is no different in sleep medicine. “Sleep Health Inequities: Sleep Deserts and Beyond” will open up the Wednesday schedule chaired by Hrayr Attarian, MD, and featuring other experts Ronald Gavidia Romero, MD; Lauren Robinson, MD; and Caroline Skolnik, MD. Topics such as inequities in sleep in the Middle Eastern population will be focused on during this session, along with other types of health inequities.
“I'm hoping that people will look beyond the everyday sleep clinical issues and think about how sleep impacts vulnerable populations, like hospital workers, prisoners, displaced people like refugees, as well as low-income families with chronic illnesses like chronic HIV infection,” Attarian, professor of neurology at Northwestern University Feinberg School of Medicine, said in an exclusive interview with AJMC.
Mental health will also be given focus during a symposium titled “Sleep, Circadian Rhythms, and Bipolar Disorder: From the Lab to the Clinic,” which will feature Jennifer Goldschmied, PhD; Helen Burgess, PhD; Lovemore Kunorozva, PhD; and Michael McCarty, MD, PhD, as they speak about the relationship between circadian rhythms and bipolar disorder. Mental health will also be featured in the Wednesday session, “Sleep’s Influence on Post Traumatic Stress Disorder and Depression Across Age Groups,” which will feature experts Joseph Dzierzewski, PhD; Kelly Kim; Ari Shechter, PhD; and Maya Schenker, PhD, talking about how different mental health disorders can affect sleep in all ages.
The diagnosis and management of narcolepsy and hypersomnia will feature in one of the first sessions of the day on Tuesday, June 4. “Advances in Narcolepsy and Idiopathic Hypersomnia Diagnosis and Management,” will feature experts Kiran Maski, MD, chair; Lucie Barateau, MD, PhD; Julie Flygare; and David Plante, MD, PhD, to discuss new areas of diagnosing and treating both sleep conditions. The session will run for 2 hours and will be held in the Grand Ballroom.
One of the first sessions of the meeting on Monday will be “Artificial Intelligence and Big Data in Sleep Medicine,” which features several doctors who will discuss how artificial intelligence (AI) and big data could play a part in the treatment of patients with sleep disorders. With different types of AI being introduced into everyday use, understanding how it can be used in medicine is of the utmost importance.
Late-breaking abstracts will also be presented on Monday, with poster sessions taking place throughout the 3 days of the conference. These posters and abstracts can provide breaking coverage of new and exciting clinical trials that can reinforce the usage of different treatments for sleep conditions and also introduce new ways to use previously known medications.
“Every year, when I go to [the] SLEEP [conference], it's always a very fruitful endeavor,” said Attarian. “Finding other colleagues, touching base with old ones…that's what I look forward to the most.”
NGS-Based Test Accurately Detects Post–Allo-HSCT Relapse in AML, MDS
February 21st 2025The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
“Expanding Access Isn’t Just About Fairness—It’s About Building Better Treatments for Everyone”
February 16th 2025Regina Barragan-Carrillo, MD, a postdoctoral fellow at City of Hope Comprehensive Cancer Center, discussed findings that show 76% of renal cell carcinoma trials take place in wealthy countries, amid news that clinical trial access for the world's poor may become even more challenging.
Read More
Amid Debate Over Diversity, RCC Trials Still Struggle to Reflect Patient Populations
February 16th 2025Abstracts presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium reflect the ongoing challenge with enrolling diverse patient populations in trials, despite stated goals.
Read More